PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.\', \'Centre for Infectious Disease Control, WHO COVID-19 reference laboratory, RIVM, Bilthoven, Netherlands.\', \'Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland.\', \'Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland.\', \'Division of Laboratory Medicine, Department of Diagnostics, Geneva University Hospitals and Geneva University, Geneva, Switzerland.\', \'Division of Laboratory Medicine, Department of Medicine, Faculty of Medicine, Geneva, Switzerland.\', \'Division of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland.\', \'Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/22221751.2020.1835448
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 33043818
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT).
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33043818>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33043818>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all